Skip to content

Eqwal NHC

Active
Private limited companyfounded 2013active for 13 yearsRue de l'Ancienne Verrerie 8, 5150 Floreffe, BelgiumKBO/BCE: BE 0537.707.424
Summary

Eqwal NHC has been active since 2013 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €907,295 and a net result of €478,740. Equity is growing by about 17% per year across the filed financial years. Its solvency ranks better than 57% of 6,030 sector peers (NACE 46, financial year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).

Overview

Activity
Wholesale of pharmaceutical and medical goods
NACE 46460Retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses NACE 47741
5th largest company by equity in Floreffe, Wholesale and retail trade sector1 site
Size
€1.7mtotal assets 2025
Staff
7.5 FTE
Equity
€907,295
Profit
€478,740
Net result +243%: 15-month year
Financial health
90 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.2%
Structure
Parent
FINICOMA · 100%
Auditor: RSM INTERAUDITAccounts filed 29 days late5 of 11 deeds read
Why 90raises risk1 change of registered office in 24 monthslowers riskLiquidity: current ratio 2.32, cash €456,991Figures for financial year 2025 (filed 29-05-2026)Equity €907,295 (51.9% of total assets)Show the evidence

Checked score

Score 2025
90 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 76% of its sector peers (NACE 46, micro)
Financial strength · tick = 2024
Strong
Solvency 77+25
equity 51.9% of total assets
Liquidity 68+22
short-term debt 33.5% · cash 26.1%
Profitability 100+20
return on assets 27.4%
Bankruptcy probability, 12 months
0.2% Very low
0%0.5%1.5%4%10%≥ 25%

About 2 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.4% (26,873 companies, NACE 46, micro)
Last 24 months 11-2024: 0.8% 12-2024: 0.8%● unchanged vs 11-2024 01-2025: 0.5%▼ -0.3 percentage points vs 12-2024 02-2025: 0.5%● unchanged vs 01-2025 03-2025: 0.5%● unchanged vs 02-2025 04-2025: 0.5%● unchanged vs 03-2025 05-2025: 0.5%● unchanged vs 04-2025 06-2025: 0.4%▼ -0.1 percentage points vs 05-2025 07-2025: 0.4%● unchanged vs 06-2025 08-2025: 0.4%● unchanged vs 07-2025 09-2025: 0.4%● unchanged vs 08-2025 10-2025: 0.4%● unchanged vs 09-2025 11-2025: 0.4%● unchanged vs 10-2025 12-2025: 0.4%● unchanged vs 11-2025 01-2026: 0.5%▲ +0.1 percentage points vs 12-2025 02-2026: 0.9%▲ +0.4 percentage points vs 01-2026 03-2026: 2.0%▲ +1.1 percentage points vs 02-2026 04-2026: 3.8%▲ +1.8 percentage points vs 03-2026 05-2026: 3.9%▲ +0.1 percentage points vs 04-2026highest value 06-2026: 0.2%▼ -3.7 percentage points vs 05-2026lowest value 07-2026: 0.2%● unchanged vs 06-2026lowest value 08-2026: 0.2%● unchanged vs 07-2026lowest value 09-2026: 0.2%● unchanged vs 08-2026lowest value 10-2026: 0.2%● unchanged vs 09-2026lowest value
Credit of up to €80,000 on 30-day terms is acceptable
Liquidity ample (current ratio 2.32, compared with 1.33 in 2024; short-term debt: 33.5% and cash: 26.1% of total assets), and 48.1% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 46, micro): better than 59% on solvency, 73% on liquidity and 95% on profitability.

The bankruptcy probability was computed on 11-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskraises riskneutral
raises risk · 1 change of registered office in 24 months
Belgian Official Gazette
lowers risk · Liquidity: current ratio 2.32, cash €456,991
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed 29-05-2026)
NBB · annual accounts
lowers risk · Equity €907,295 (51.9% of total assets)
NBB · annual accounts
neutral · Filed after the deadline
The financial year that closed on 30-09-2025 was due by 30-04-2026 and was filed on 29-05-2026, 29 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 10 filings
Deviation from the deadline
2025
29 days late
2024
45 days early
2023
29 days late
2022
56 days late
2021
28 days late
2020
12 days late
2019
14 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 18 days after the deadline; the sector median (NACE 46) for financial year 2024 is 3 days before the deadline, and 39% of those companies filed late.

Searched, nothing found (1)
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · full…
  2. Capital & shares · RestructuringShareholding · Power of attorney…
  3. Registered officeRegistered-office move

Key points

  • Positive: Equity rose in 2025from €428,555 to €907,295 ▲ 112% View
  • Positive: 5th largest company by equity in Floreffe, Wholesale and retail trade sectorin the Checked rankings No. 5 View
  • Controlled by FINICOMAultimately: Ovalie Développement 2 100% View
  • Merger with EQWAL DMSmerger on 06-05-2026 2026 View
  • Positive: 7 profitable years in a rowprofit 2025: €478,740 7 years View

By topic

Financials

Financial year
2025
Total assets
€1.7m
Profit
€478,740
Solvency
51.9%
Total assets▲ 10.8%
Net result
20192025
Go to Financials

Timeline

Events
20
Since
2015
  1. 11-02-2026Restructuring
  2. 30-10-2025Permanent representative: Jonas Uytterhaegen
  3. 14-10-2025Amendment of the articles · Name
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
Wholesale of pharmaceutical and medical goodsNACE 46460
Founded
27-08-2013
Year ends
30-09
Peppol
Reachable for e-invoices
Go to Company details

Articles of association

Provisions read
3
Purpose
“Toute activité liée directement ou indirectement à la profession d'infirmière, la…” (deed in French)
Go to Articles of association

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.